XML 21 R14.htm IDEA: XBRL DOCUMENT v2.3.0.15
Segment Reporting
9 Months Ended
Sep. 30, 2011
Segment Reporting [Abstract] 
SEGMENT REPORTING
9) SEGMENT REPORTING
The Company has two reportable segments: Photodynamic Therapy (PDT) Drug and Device Products and Non-Photodynamic Therapy (Non-PDT) Products. Operating segments are defined as components of the Company for which separate financial information is available to manage resources and evaluate performance regularly by the chief operating decision maker. The table below presents the revenues, costs of revenues and gross margins attributable to these reportable segments for the periods presented. The Company does not allocate research and development, selling and marketing and general and administrative expenses to its reportable segments, because these activities are managed at a corporate level.
                                 
    Three-months ended     Nine-months ended  
    September 30,
2011
    September 30,
2010
    September 30,
2011
    September 30,
2010
 
     
REVENUES
                               
PDT drug and device product revenues
  $ 9,374,000     $ 7,837,000     $ 30,027,000     $ 24,544,000  
Non-PDT product revenues
    74,000       179,000       266,000       886,000  
     
 
                               
Total revenues
    9,448,000       8,016,000       30,293,000       25,430,000  
     
                                 
    Three-months ended     Nine-months ended  
    September 30,     September 30,     September 30,     September 30,  
    2011     2010     2011     2010  
     
COSTS OF REVENUES
                               
PDT drug and device cost of product revenues
    1,398,000       1,305,000       4,472,000       4,348,000  
Non-PDT cost of product revenues
    139,000       323,000       419,000       880,000  
     
 
                               
Total cost of revenues
    1,537,000       1,628,000       4,891,000       5,228,000  
GROSS MARGIN
                               
PDT drug and device product gross margin
    7,976,000       6,532,000       25,555,000       20,196,000  
Non-PDT gross margin
    (65,000 )     (144,000 )     (153,000 )     6,000  
     
 
                               
Total gross margin
  $ 7,911,000     $ 6,388,000     $ 25,402,000     $ 20,202,000  
     
During the three and nine-month periods ended September 30, 2011 and 2010, the Company derived revenues from the following geographies based on the location of the customer (as a percentage of revenues):
                                 
    Three-months ended     Nine-months ended  
    September 30,     September 30,     September 30,     September 30,  
    2011     2010     2011     2010  
     
United States
    83 %     89 %     93 %     94 %
Canada
    1 %     2 %     1 %     2 %
Korea
    16 %     1 %     6 %     1 %
Latin America
    %     8 %     %     3 %
     
Total
    100 %     100 %     100 %     100 %